{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Pibrozelesin_Hydrobromide",
  "nciThesaurus": {
    "casRegistry": "148778-32-9",
    "chebiId": "",
    "chemicalFormula": "C32H36BrN5O8.BrH",
    "definition": "The hydrobromide salt form of pibrozelesin, a semisynthetic water-soluble derivative of the antineoplastic antibiotic duocarmycin B2, with antineoplastic activity. Activated by carboxyl esterase, pibrozelesin alkylates DNA by binding to adenine-thymine (A-T)-rich sequences in the minor groove of DNA, thereby inhibiting DNA replication and inducing apoptosis.",
    "fdaUniiCode": "0481JCC90T",
    "identifier": "C73816",
    "preferredName": "Pibrozelesin Hydrobromide",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C2156"
    ],
    "synonyms": [
      "PIBROZELESIN HYDROBROMIDE",
      "Pibrozelesin Hydrobromide"
    ]
  }
}